UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting

Cell reports (Cambridge), 2015-09, Vol.12 (10), p.1668-1677

2015

Volltextzugriff (PDF)

Cytotoxic and Regulatory Properties of Circulating Vδ1+ γδ T Cells: A New Player on the Cell Therapy Field?

Molecular therapy, 2014-08, Vol.22 (8), p.1416-1422

2014

Volltextzugriff (PDF)

In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

PloS one, 2016-12, Vol.11 (12), p.e0166891

2016

Volltextzugriff (PDF)

A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas

Scientific reports, 2021-10, Vol.11 (1), p.21133-8, Article 21133

2021

Volltextzugriff (PDF)

Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy

PloS one, 2013, Vol.8 (1), p.e51805

2013

Volltextzugriff (PDF)

Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma

Journal of Immunology Research, 2016-01, Vol.2016 (2016), p.1-10

2016

Volltextzugriff (PDF)

A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2/3 (CIN2/3)

Gynecologic oncology, 2016-02, Vol.140 (2), p.245-252

2016

Volltextzugriff (PDF)

Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells

PloS one, 2014-05, Vol.9 (5), p.e97335

2014

Volltextzugriff (PDF)

Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma

PloS one, 2015-05, Vol.10 (5), p.e0122387-e0122387

2015

Volltextzugriff (PDF)

CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells

PloS one, 2013-08, Vol.8 (8), p.e68729-e68729

2013

Volltextzugriff (PDF)

Cytotoxic and Regulatory Properties of Circulating V delta 1 + gamma delta T Cells: A New Player on the Cell Therapy Field?

Molecular therapy, 2014-08, Vol.22 (8), p.1416-1422

2014

Volltextzugriff (PDF)

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

PloS one, 2017-02, Vol.12 (2), p.e0172640-e0172640

2017

Volltextzugriff (PDF)

In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study

Medicine (Baltimore), 2016-09, Vol.95 (39), p.e4909-e4909

2016

Volltextzugriff (PDF)

Persistence pays off for γδ T-cell therapies

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.397-398

Lamb, Lawrence S

2013

Volltextzugriff (PDF)

Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression

Cancers, 2022-05, Vol.14 (9), p.2339

2022

Volltextzugriff (PDF)

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

Journal of neuro-oncology, 2011, Vol.101 (2), p.179-188

2011

Volltextzugriff (PDF)

Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis

Bone marrow transplantation (Basingstoke), 2018-06, Vol.53 (6), p.766-769

2018

Volltextzugriff (PDF)

The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation

Cancer Immunology, Immunotherapy, 2015-05, Vol.64 (5), p.551-562

2015

Volltextzugriff (PDF)

Glioma cells display complex cell surface topographies that resist the actions of cytolytic effector lymphocytes

The Journal of immunology (1950), 2010-10, Vol.185 (8), p.4793-4803

2010

Volltextzugriff (PDF)

Improving the safety of cell therapy products by suicide gene transfer

Frontiers in pharmacology, 2014-11, Vol.5, p.254-254

2014

Volltextzugriff (PDF)

Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma

Cancers, 2024-08, Vol.16 (16), p.2852

2024

Volltextzugriff (PDF)

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Bone marrow transplantation (Basingstoke), 2018-10, Vol.53 (10), p.1345-1348

2018

Volltextzugriff (PDF)

Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications

Biology of blood and marrow transplantation, 2019-02, Vol.25 (2), p.233-238

2019

Volltextzugriff (PDF)

Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies Using a Reduced-Intensity Conditioning Regimen and Third-Party Mesenchymal Stromal Cells

Biology of blood and marrow transplantation, 2014-04, Vol.20 (4), p.581-586

2014

Volltextzugriff (PDF)

Preclinical evaluation of ex vivo expanded/activated gamma delta T cells for immunotherapy of glioblastoma multiforme

Journal of neuro-oncology, 2011-01, Vol.101 (2), p.179-188

2011

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(130)

Publikationsform

Artikel
(146)
Buchkapitel
(1)

Sprache

Englisch
(147)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(43)
Life Sciences & Biomedicine
(40)
Male
(21)
Animals
(20)
Immunotherapy
(20)
Female
(19)
Physical Sciences
(18)
Lymphocytes
(15)
Lymphocytes T
(13)
Oncology
(13)
70 Plasma Physics And Fusion Technology
(12)
Immunology
(12)
Medicine
(11)
Physics
(11)
Tumors
(11)
Cytotoxicity
(10)
Hematology
(10)
Ligands
(10)
Mice
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting

Cytotoxic and Regulatory Properties of Circulating Vδ1+ γδ T Cells: A New Player on the Cell Therapy Field?

In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas

Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy

Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma

A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2/3 (CIN2/3)

Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells

Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma

CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells

Cytotoxic and Regulatory Properties of Circulating V delta 1 + gamma delta T Cells: A New Player on the Cell Therapy Field?

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study

Persistence pays off for γδ T-cell therapies

Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis

The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation

Glioma cells display complex cell surface topographies that resist the actions of cytolytic effector lymphocytes

Improving the safety of cell therapy products by suicide gene transfer

Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications

Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies Using a Reduced-Intensity Conditioning Regimen and Third-Party Mesenchymal Stromal Cells

Preclinical evaluation of ex vivo expanded/activated gamma delta T cells for immunotherapy of glioblastoma multiforme

Suchergebnisse filtern